Related Experiment Video
Updated: Jan 11, 2026

Synovial Fluid Analysis to Identify Osteoarthritis
Published on: October 20, 2022
Paraneoplastic Remitting Seronegative Symmetrical Synovitis With Pitting Edema: A Systematic Review of Case Reports
Ryuichi Ohta1, Yoshinori Ryu1, Kaoru Tanaka2
1Community Care, Unnan City Hospital, Unnan, JPN.
Abstract:
Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) is an uncommon inflammatory disorder that may occur as a paraneoplastic manifestation. To clarify its clinical profile, we reviewed published cases and observational studies reporting paraneoplastic RS3PE. A total of 120 patients were identified, including 40 individual case reports and four observational cohorts. The mean age was 69 years, and men accounted for approximately 70-80% of patients. Associated malignancies were diverse, with prostate (22%), lung (18%), and gastrointestinal cancers (16%) being the most frequent among solid tumors, alongside hematologic malignancies such as lymphoma and leukemia (12%). The hallmark clinical presentation was symmetrical synovitis of the hands and feet with pitting edema. Systemic features were common, including fever (36%), weight loss (28%), and fatigue (21%). Corticosteroid responsiveness varied: pooled analysis demonstrated an overall response rate of 78.4%, but outcomes differed by region. For example, two Japanese and U.S. cohorts reported remission in over 85% of patients, whereas a Chinese cohort described only 42.8% achieving remission. Relapses were frequent and often paralleled cancer progression, reinforcing the link between RS3PE activity and malignancy status. In 59.5% of cases, RS3PE was diagnosed simultaneously with cancer, while in others it preceded (25%) or followed (15%) cancer diagnosis. These findings suggest that paraneoplastic RS3PE is a distinct clinical entity and a sentinel marker of malignancy. Comprehensive cancer screening should be prioritized in affected patients, particularly older men with systemic symptoms or inadequate steroid response. Further multicenter research is needed to establish biomarkers and optimize management strategies.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Pericarditis II: Clinical Features and Diagnostic Tests
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Nephrotic Syndrome III : Nursing Management
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:

